These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 30557050

  • 1. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    Cannella R, Rangaswamy B, Minervini MI, Borhani AA, Tsung A, Furlan A.
    AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images.
    Cannella R, Borhani AA, Minervini MI, Tsung A, Furlan A.
    Abdom Radiol (NY); 2019 Apr; 44(4):1323-1330. PubMed ID: 30267107
    [Abstract] [Full Text] [Related]

  • 3. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.
    Auer TA, Walter-Rittel T, Geisel D, Schöning W, Schmelzle M, Müller T, Sinn B, Denecke T, Hamm B, Fehrenbach U.
    BMC Med Imaging; 2021 Feb 15; 21(1):28. PubMed ID: 33588783
    [Abstract] [Full Text] [Related]

  • 4. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
    Roux M, Pigneur F, Baranes L, Calderaro J, Chiaradia M, Decaens T, Kastahian S, Charles-Nelson A, Tselikas L, Costentin C, Laurent A, Azoulay D, Mallat A, Rahmouni A, Luciani A.
    Abdom Radiol (NY); 2018 Jul 15; 43(7):1670-1681. PubMed ID: 29110059
    [Abstract] [Full Text] [Related]

  • 5. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
    Kim TH, Woo S, Ebrahimzadeh S, McInnes MDF, Gerst SR, Do RK.
    AJR Am J Roentgenol; 2023 Jan 15; 220(1):28-38. PubMed ID: 35920706
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma.
    Bilreiro C, Soler JC, Ayuso JR, Caseiro-Alves F, Ayuso C.
    Radiol Med; 2021 Nov 15; 126(11):1379-1387. PubMed ID: 34287759
    [Abstract] [Full Text] [Related]

  • 7. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
    Zarghampour M, Fouladi DF, Pandey A, Ghasabeh MA, Pandey P, Varzaneh FN, Khoshpouri P, Shao N, Pan L, Grimm R, Kamel IR.
    J Magn Reson Imaging; 2018 Oct 15; 48(4):1080-1090. PubMed ID: 29630756
    [Abstract] [Full Text] [Related]

  • 8. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Reizine E, Amaddeo G, Pigneur F, Baranes L, Legou F, Mulé S, Zegai B, Roche V, Laurent A, Rahmouni A, Calderaro J, Luciani A.
    Eur Radiol; 2018 Oct 15; 28(10):4243-4253. PubMed ID: 29721686
    [Abstract] [Full Text] [Related]

  • 9. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
    Roux M, Pigneur F, Calderaro J, Baranes L, Chiaradia M, Tselikas L, Decaens T, Costentin C, Laurent A, Azoulay D, Mallat A, Zafrani ES, Rahmouni A, Luciani A.
    J Magn Reson Imaging; 2015 Nov 15; 42(5):1249-58. PubMed ID: 25851028
    [Abstract] [Full Text] [Related]

  • 10. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    Vanhooymissen IJSML, Thomeer MG, Braun LMM, Gest B, van Koeverden S, Willemssen FE, Hunink M, De Man RA, Ijzermans JN, Dwarkasing RS.
    J Magn Reson Imaging; 2019 Mar 15; 49(3):700-710. PubMed ID: 30252977
    [Abstract] [Full Text] [Related]

  • 11. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis.
    Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, Gambarini S, Donato F, Colagrande S.
    Radiology; 2012 Feb 15; 262(2):520-9. PubMed ID: 22282184
    [Abstract] [Full Text] [Related]

  • 12. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
    Kitao A, Matsui O, Yoneda N, Kita R, Kozaka K, Kobayashi S, Gabata T.
    AJR Am J Roentgenol; 2018 Aug 15; 211(2):347-357. PubMed ID: 29708786
    [Abstract] [Full Text] [Related]

  • 13. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.
    Kim JW, Lee CH, Kim SB, Park BN, Park YS, Lee J, Park CM.
    J Magn Reson Imaging; 2017 Jun 15; 45(6):1599-1608. PubMed ID: 27726242
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
    Alamri TM, Cerny M, Al Shaikh M, Billiard JS, Olivié D, Chagnon M, Tang A.
    Abdom Radiol (NY); 2023 Mar 15; 48(3):874-885. PubMed ID: 36528729
    [Abstract] [Full Text] [Related]

  • 15. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
    Lebert P, Adens-Fauquembergue M, Azahaf M, Gnemmi V, Behal H, Luciani A, Ernst O.
    Eur Radiol; 2019 Nov 15; 29(11):5742-5751. PubMed ID: 30993437
    [Abstract] [Full Text] [Related]

  • 16. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.
    Nowicki TK, Markiet K, Izycka-Swieszewska E, Dziadziuszko K, Studniarek M, Szurowska E.
    BMC Gastroenterol; 2018 Jan 15; 18(1):10. PubMed ID: 29334905
    [Abstract] [Full Text] [Related]

  • 17. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma.
    Park HJ, Byun JH, Kang JH, Kang HJ, Yu E, Lee SJ, Kim SY, Won HJ, Shin YM, Kim PN.
    Eur J Radiol; 2021 Jun 15; 139():109730. PubMed ID: 33930719
    [Abstract] [Full Text] [Related]

  • 18. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
    Denis de Senneville B, Frulio N, Laumonier H, Salut C, Lafitte L, Trillaud H.
    Eur Radiol; 2020 May 15; 30(5):2995-3003. PubMed ID: 32002637
    [Abstract] [Full Text] [Related]

  • 19. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
    Agarwal S, Fuentes-Orrego JM, Arnason T, Misdraji J, Jhaveri KS, Harisinghani M, Hahn PF.
    AJR Am J Roentgenol; 2014 Oct 15; 203(4):W408-14. PubMed ID: 25055198
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review.
    Guo Y, Li W, Cai W, Zhang Y, Fang Y, Hong G.
    Int J Med Sci; 2017 Oct 15; 14(7):668-674. PubMed ID: 28824299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.